AAAAAA

   
Results: 1-11 |
Results: 11
BISPHOSPHONATE EFFECTS AND THE BONE REMODELING TRANSIENT
Authors: HEANEY RP YATES AJ SANTORA AC
Citation: Rp. Heaney et al., BISPHOSPHONATE EFFECTS AND THE BONE REMODELING TRANSIENT, Journal of bone and mineral research, 12(8), 1997, pp. 1143-1151
METAANALYSIS OF PREVENTION OF NONVERTEBRAL FRACTURES BY ALENDRONATE -REPLY
Authors: SHAPIRO DR SANTORA AC KARPF DB
Citation: Dr. Shapiro et al., METAANALYSIS OF PREVENTION OF NONVERTEBRAL FRACTURES BY ALENDRONATE -REPLY, JAMA, the journal of the American Medical Association, 278(8), 1997, pp. 631-632
PREVENTION OF NONVERTEBRAL FRACTURES BY ALENDRONATE - A METAANALYSIS
Authors: KARPF DB SHAPIRO DR SEEMAN E ENSRUD KE JOHNSTON CC ADAMI S HARRIS ST SANTORA AC HIRSCH LJ OPPENHEIMER L THOMPSON D
Citation: Db. Karpf et al., PREVENTION OF NONVERTEBRAL FRACTURES BY ALENDRONATE - A METAANALYSIS, JAMA, the journal of the American Medical Association, 277(14), 1997, pp. 1159-1164
INCREMENTS IN BONE-MINERAL DENSITY OF THE LUMBAR SPINE AND HIP AND SUPPRESSION OF BONE TURNOVER ARE MAINTAINED AFTER DISCONTINUATION OF ALENDRONATE IN POSTMENOPAUSAL WOMEN
Authors: STOCK JL BELL NH CHESNUT CH ENSRUD KE GENANT HK HARRIS ST MCCLUNG MR SINGER FR YOOD RA PRYORTILLOTSON S WEI L SANTORA AC
Citation: Jl. Stock et al., INCREMENTS IN BONE-MINERAL DENSITY OF THE LUMBAR SPINE AND HIP AND SUPPRESSION OF BONE TURNOVER ARE MAINTAINED AFTER DISCONTINUATION OF ALENDRONATE IN POSTMENOPAUSAL WOMEN, The American journal of medicine, 103(4), 1997, pp. 291-297
ORAL ALENDRONATE INDUCES PROGRESSIVE INCREASES IN BONE MASS OF THE SPINE, HIP, AND TOTAL-BODY OVER 3 YEARS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Authors: DEVOGELAER JP BROLL H CORREAROTTER R CUMMING DC DEDEUXCHAISNES CN GEUSENS P HOSKING D JAEGER P KAUFMAN JM LEITE M LEON J LIBERMAN U MENKES CJ MEUNIER PJ REID I RODRIGUEZ J ROMANOWICZ A SEEMAN E VERMEULEN A HIRSCH LJ LOMBARDI A PLEZIA K SANTORA AC YATES AJ YUAN W
Citation: Jp. Devogelaer et al., ORAL ALENDRONATE INDUCES PROGRESSIVE INCREASES IN BONE MASS OF THE SPINE, HIP, AND TOTAL-BODY OVER 3 YEARS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 18(2), 1996, pp. 141-150
EFFECT OF 3 YEARS OF ORAL ALENDRONATE TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Authors: TUCCI JR TONINO RP EMKEY RD PEVERLY CA KHER U SANTORA AC
Citation: Jr. Tucci et al., EFFECT OF 3 YEARS OF ORAL ALENDRONATE TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, The American journal of medicine, 101(5), 1996, pp. 488-501
NONVERTEBRAL FRACTURE INCIDENCE IN PATIENTS TREATED WITH ALENDRONATE
Authors: SHAPIRO DR THOMPSON DE KARPF DB SANTORA AC LOMBARDI A HIRSCH LJ SEEMAN E BELL N ORTOLANI S HARRIS ST ENSRUD K
Citation: Dr. Shapiro et al., NONVERTEBRAL FRACTURE INCIDENCE IN PATIENTS TREATED WITH ALENDRONATE, Journal of bone and mineral research, 10, 1995, pp. 176-176
EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS
Authors: LIBERMAN UA WEISS SR BROLL J MINNE HW QUAN H BELL NH RODRIGUEZPORTALES J DOWNS RW DEQUEKER J FAVUS M SEEMAN E RECKER RR CAPIZZI T SANTORA AC LOMBARDI A SHAH RV HIRSCH LJ KARPF DB
Citation: Ua. Liberman et al., EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS, The New England journal of medicine, 333(22), 1995, pp. 1437-1443
ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING
Authors: CHESTNUT CH MCCLUNG MR ENSRUD KE BELL NH GENANT HK HARRIS ST SINGER FR STOCK JL YOOD RA DELMAS PD KHER U PRYORTILLOTSON S SANTORA AC
Citation: Ch. Chestnut et al., ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING, The American journal of medicine, 99(2), 1995, pp. 144-152
ORAL ALENDRONATE TREATMENT OF BONE LOSS IN POSTMENOPAUSAL OSTEOPENIC WOMEN
Authors: SANTORA AC BELL NH CHESNUT CH ENSRUD K GENANT HK GRIMM R HARRIS ST MCCLUNG MR SINGER FR STOCK JL YOOD RA DELMAS PD PRYORTILLOTSON S WEINBERG J
Citation: Ac. Santora et al., ORAL ALENDRONATE TREATMENT OF BONE LOSS IN POSTMENOPAUSAL OSTEOPENIC WOMEN, Journal of bone and mineral research, 8, 1993, pp. 190000131-190000131
CLINICAL-TRIALS WITH BISPHOSPHONATES
Authors: LOMBARDI A SANTORA AC
Citation: A. Lombardi et Ac. Santora, CLINICAL-TRIALS WITH BISPHOSPHONATES, Bone and mineral, 22, 1993, pp. 190000059-190000070
Risultati: 1-11 |